Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Cancer

Explore clinical trials studying Head and Neck Cancer. Study availability and eligibility vary by location and protocol.

1,172 public trials 218 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Cancer trial results

Recruiting

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

NCT06607406

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma HNSCC, +2 more
Locations
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • Advocate Aurora Radiation Oncology Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

NCT06970275

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • AZ Maria Middelares Ghent, Belgium
  • Universitäts-klinikum Essen Essen, North Rhine-Westphalia, Germany
  • UMCG Groningen, Netherlands
  • University Hospitals Coventry and Warwickshire (UHCW) NHS Trust Coventry, West Midlands, United Kingdom
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Site 105 - START Los Angeles Los Angeles, California, United States
  • Site 104 - START New Jersey East Brunswick, New Jersey, United States
View Trial Details

Related conditions